President and CEO of Seattle Genetics Inc. (SGEN, Financial) Clay B Siegall sells 200,000 shares of SGEN on 03/17/2011 at an average price of $14.09 a share.
Seattle Genetics Inc. has a market cap of $1.62 billion; its shares were traded at around $14.28 with and P/S ratio of 15.2. Seattle Genetics Inc. had an annual average earning growth of 2.2% over the past 10 years.
For the complete insider trading history of SGEN, click here.
Seattle Genetics Inc. has a market cap of $1.62 billion; its shares were traded at around $14.28 with and P/S ratio of 15.2. Seattle Genetics Inc. had an annual average earning growth of 2.2% over the past 10 years.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 48,197 shares of SGEN stock on 02/02/2011 at the average price of 15.5. Capital (gp), Llc 14159 owns at least 303,449 shares after this. The price of the stock has decreased by 7.87% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 1,751,803 shares of SGEN stock on 02/02/2011 at the average price of 15.5. Brothers Life Sciences C Baker owns at least 13,470,692 shares after this. The price of the stock has decreased by 7.87% since.
- Sell: EVP, Process Sciences Morris Rosenberg sold 25,000 shares of SGEN stock on 12/15/2010 at the average price of 16.22. The price of the stock has decreased by 11.96% since.
- Sell: EVP, Process Sciences Morris Rosenberg sold 25,000 shares of SGEN stock on 12/02/2010 at the average price of 15.81. The price of the stock has decreased by 9.68% since.
- Sell: EVP, Process Sciences Morris Rosenberg sold 25,000 shares of SGEN stock on 11/04/2010 at the average price of 14.7. The price of the stock has decreased by 2.86% since.
For the complete insider trading history of SGEN, click here.
